Vivendal 320 mg Filmdragerad tablett

Kraj: Szwecja

Język: szwedzki

Źródło: Läkemedelsverket (Medical Products Agency)

Kup teraz

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
17-05-2018

Składnik aktywny:

valsartan

Dostępny od:

Sandoz A/S

Kod ATC:

C09CA03

INN (International Nazwa):

valsartan

Dawkowanie:

320 mg

Forma farmaceutyczna:

Filmdragerad tablett

Skład:

valsartan 320 mg Aktiv substans

Klasa:

Apotek

Typ recepty:

Receptbelagt

Dziedzina terapeutyczna:

Valsartan

Podsumowanie produktu:

Förpacknings: Blister, 7 tabletter (plast/Al); Blister, 7 tabletter (Al); Blister, 10 tabletter (plast/Al); Blister, 14 tabletter (plast/Al); Blister, 15 tabletter (plast/Al); Blister, 20 tabletter (plast/Al); Blister, 28 tabletter (plast/Al); Blister, 30 tabletter (plast/Al); Blister, 50 tabletter (plast/Al); Blister, 50x1 tabletter (plast/Al); Blister, 56 tabletter (plast/Al); Blister, 60 tabletter (plast/Al); Blister, 84 tabletter (plast/Al); Blister, 90 tabletter (plast/Al); Blister, 98 tabletter (plast/Al); Blister, 100 tabletter (plast/Al); Blister, 280 tabletter (plast/Al); Blister, 10 tabletter (Al); Blister, 14 tabletter (Al); Blister, 15 tabletter (Al); Blister, 20 tabletter (Al); Blister, 28 tabletter (Al); Blister, 30 tabletter (Al); Blister, 50 tabletter (Al); Blister, 50x1 tabletter (Al); Blister, 56 tabletter (Al); Blister, 60 tabletter (Al); Blister, 84 tabletter (Al); Blister, 90 tabletter (Al); Blister, 98 tabletter (Al); Blister, 100 tabletter (Al); Blister, 280 tabletter (Al)

Status autoryzacji:

Godkänd

Data autoryzacji:

2010-12-10

Ulotka dla pacjenta

                                PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
VIVENDAL 40 MG FILM-COATED TABLETS
VIVENDAL 80 MG FILM-COATED TABLETS
VIVENDAL 160 MG FILM-COATED TABLETS
VIVENDAL 320 MG FILM-COATED TABLETS
valsartan
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Vivendal is and what it is used for
2.
What you need to know before you take Vivendal
3.
How to take Vivendal
4.
Possible side effects
5.
How to store Vivendal
6.
Contents of the pack and other information
1.
WHAT VIVENDAL IS AND WHAT IT IS USED FOR
Vivendal belongs to a class of medicines known as angiotensin II
receptor antagonist, which help to
control high blood pressure. Angiotensin II is a substance in the body
that causes vessels to tighten,
thus causing your blood pressure to increase. Vivendal works by
blocking the effect of angiotensin II.
As a result, blood vessels relax and blood pressure is lowered.
Vivendal 40 mg film-coated tablets
CAN BE USED FOR THREE DIFFERENT CONDITIONS:

TO TREAT HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS 6 TO 18
YEARS OF AGE.
High blood
pressure increases the workload on the heart and arteries. If not
treated it can damage the blood
vessels of the brain, heart, and kidneys, and may result in a stroke,
heart failure, or kidney
failure. High blood pressure increases the risk of heart attacks.
Lowering your blood pressure to
normal reduces the risk of developing these disorders.

TO TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK
(myocardial infarction)
.
“Recent” here
means between 12 hours and 1
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta angielski 17-05-2018
Charakterystyka produktu Charakterystyka produktu angielski 17-05-2018
Sprawozdanie z oceny publicznego Sprawozdanie z oceny publicznego angielski 21-02-2013

Wyszukaj powiadomienia związane z tym produktem